Alzheimer’s disease is among the most prevalent forms of dementia, responsible for somewhere between 60 % and 80 % of all registered dementia cases. It is generally diagnosed as a set of disorders that disrupt mental function.
Every year, since 2012, September 21, marked as World Alzheimer’s Day in the framework of World Alzheimer’s Month, is aiming to raise awareness and challenge the lack of understanding and knowledge surrounding Alzheimer’s disease and dementia.
Working together with medicinal chemistry professionals and supporting their drug development projects to combat different forms of dementia, in particular, Alzheimer’s disease, Life Chemicals is offering the following expertly selected libraries:
- CNS Screening Library: a collection of 22,300 potentially CNS-active compounds, selected according to up-to-date studies
- NMDA Receptor Screening Library: 1,000 potential NMDA channel blockers, selected with molecular docking
- Alzheimer’s Targeted Compound Set: 330 close analogues of known inhibitors of the reported therapeutic targets for Alzheimer's disease 
Please, contact us at firstname.lastname@example.org for any additional information and price quotations.
Take a look at our dedicated blog post.
Download SD files with compound structures directly in our Downloads section
Custom compound selection based on specific parameters can be performed on request, with competitive pricing and the most convenient terms provided.
Figure 1. The Life Chemicals Alzheimer’s Targeted Compound Set provides analogs of known inhibitors of the reported therapeutic targets for Alzheimer's disease, obtained using a 2D fingerprint similarity search.